Feasibility of trastuzumab as monotherapy for HER2 blockade in HER2-positive breast cancer patients with 2cm<tumor size≤3cm

First Author / 第一作者

Janghee Lee

Institution / 單位

Dongtan Sacred Heart Hospital, Hallym University, Republic of Korea Yonsei University Graduate School, Seoul, Republic of Korea

Audio / 音訊檔

Author Group / 作者群

Janghee Lee, M.D., Youri Park, M.D., Soojung Kim, Yeonjoo Kwon, Jung Ho Park, Sanghwa Kim, Young Ah Lim, Hee-Joon Kang, Doyil Kim

Author Group Institution/ 作者群單位

Dongtan Sacred Heart Hospital, Hallym University, Republic of Korea Hallym University Sacred Heart Hospital, Hallym University, Republic of Korea

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Early breast cancer, trastuzumab, HER2

Back to list